Literature DB >> 18945598

In vitro activity of linezolid against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR)-TB isolates.

Therdsak Prammananan, Angkana Chaiprasert, Manoon Leechawengwongs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18945598     DOI： 10.1016/j.ijantimicag.2008.08.007

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  4 in total

1.  An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.

Authors:  Amit Kaushik; Abigail M Heuer; Drew T Bell; Jeffrey C Culhane; David C Ebner; Nicole Parrish; J Thomas Ippoliti; Gyanu Lamichhane
Journal:  Bioorg Med Chem Lett       Date:  2016-06-09       Impact factor: 2.823

2.  Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.

Authors:  D H Vu; M S Bolhuis; R A Koster; B Greijdanus; W C M de Lange; R van Altena; J R B J Brouwers; D R A Uges; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

3.  Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK.

Authors:  Lara J Wolfson; Anna Walker; Robert Hettle; Xiaoyan Lu; Chrispin Kambili; Andrew Murungi; Gerhart Knerer
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  Pyrosequencing for rapid detection of tuberculosis resistance in clinical isolates and sputum samples from re-treatment pulmonary tuberculosis patients.

Authors:  Ruijuan Zheng; Changtai Zhu; Qi Guo; Lianhua Qin; Jie Wang; Junmei Lu; Haiyan Cui; Zhenling Cui; Baoxue Ge; Jinming Liu; Zhongyi Hu
Journal:  BMC Infect Dis       Date:  2014-04-13       Impact factor: 3.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.